Antibody Therapeutics Patients First!

공지사항

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Weon Sup Lee, Head of R&D center and PharmAbcine R&D staffs have attended and presented their R&D progress of both TTAC-0001 (Tanibirumab) and PMC-309 projects funded by KDDF
  • 글쓴이 관리자
  • 작성일 2018-09-10 09:40:46
  • 조회수 293
PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Weon Sup Lee, Head of R&D center and PharmAbcine R&D staffs have attended
and presented their R&D progress of both TTAC-0001 (Tanibirumab) and PMC-309 projects funded by KDDF at KDDF R&D workshop 2018 (September 6-7) at Sun Valley Hotel in Yeoju, KOREA.

목록





이전글 Interview of Dr. Jin-San Yoo, CEO of PharmAbcine with informa
다음글 다음글이 없습니다.